Updated September 2026One line has two pricesPepHaūs review
The semaglutide rungs are clear. The tirzepatide line carries two prices and nothing says which applies.
The verdict
PepHaūs publishes from $152 a month for compounded semaglutide on the quarterly plan, read August 2026, against $179 otherwise. Its tirzepatide line carries two figures that cannot be reconciled, so no price for it is published here. Fifty states are covered.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- $152/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
PepHaūs sells both molecules by injection across fifty states. The semaglutide line carries a quarterly rate and a higher one outside it. The tirzepatide line does not resolve.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state plans. The clinician is not described.
On semaglutide the structure is a two-rung ladder and both rungs are published. On tirzepatide two different figures appear and nothing states which one a buyer meets.
What happens when the dose goes up?
Nothing is published about dose. The semaglutide figures carry from wording, so the quarterly rate is itself a floor.
What the price includes
Six months of semaglutide at $152 is $912 on the quarterly plan and $1,074 otherwise, a gap of $27 a month. The tirzepatide line shows $215 in one place and $246 in another, with nothing to say which is the rate. Two prices for one product is not a rounding difference, so no figure for that line is carried here.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Coverage across all fifty states
- Strength: Both rungs published on each line
- Strength: The semaglutide rungs are both published
- Limitation: The tirzepatide line shows two prices
- Limitation: No milligram dose stated
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about PepHaūs. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will commit a quarter for a modest saving.
- Wrong for
- A reader needing a settled figure at their dose.
How PepHaūs compares
| Seller | Who it suits | Go |
|---|---|---|
 Obu Health | Readers who value a site that agrees with itself | See Obu Health → |
| NuDay Rx | Readers wanting an oral semaglutide at the injection price | See NuDay Rx → |
| Prime Doctor RX | Readers who count charges rather than months | See Prime Doctor RX → |
More GLP-1 telehealth sellers reviews: ARSYNL RxAscend MedicalAVARA RxBayan HealthBetterMe RxBioGlow Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does the quarterly plan save?
- $27 a month on semaglutide, at $152 against $179.
- What does tirzepatide cost?
- Unresolved. The seller shows $215 in one place and $246 in another. Nothing states which applies, so no tirzepatide figure is carried here.
- Where does PepHaūs ship?
- All fifty states are recorded.
- Is PepHaūs legit?
- PepHaūs is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is PepHaūs expensive compared with other GLP-1 telehealth sellers?
- PepHaūs publishes a starting figure of $152/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts PepHaūs below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.